Therapeutic Strategies against Ebola Virus Infection
Since the 2014–2016 epidemic, Ebola virus (EBOV) has spread to several countries and has become a major threat to global health. EBOV is a risk group 4 pathogen, which imposes significant obstacles for the development of countermeasures against the virus. Efforts have been made to develop anti-EBOV...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
MDPI AG
2022-03-01
|
| Saila: | Viruses |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1999-4915/14/3/579 |